Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New treatment for AIDS-related pain progresses to clinical testing

Jan. 4, 1999

Novo Nordisk describes novel muscarinic cholinergic receptor modulators

Dec. 30, 1998

First U.S. marketing approval for Cephalon: Provigil cleared for narcolepsy-associated EDS

Dec. 29, 1998

YM-872: neuroprotective effects in animal model indicate potential in acute ischemic stroke

Dec. 29, 1998

Peripheral nerve regeneration enhanced by hyaluronic acid in rat model

Dec. 29, 1998

More CRF antagonists emerge from Janssen/Neurocrine Biosciences collaboration

Dec. 29, 1998

Guilford patents NAALADase inhibitors for glutamate abnormalities, prostate conditions

Dec. 28, 1998

Revolutionary drugs for Alzheimer's ready for human testing described by Nymox

Dec. 28, 1998

Agents for epilepsy, stroke and brain, spinal cord trauma in development at Novartis

Dec. 28, 1998

Collaborative work by Janssen and Neurocrine Biosciences related to CRF antagonists

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...